Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004883
Status:
COMPLETED
Last Update Posted:
2013-01-16
First Post:
2000-03-07
Brief Title:
Trastuzumab in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer That Overexpresses HER2
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Stage IV Non-small Cell Lung Cancer |
| Recurrent Non-small Cell Lung Cancer |
| Stage IIIB Non-small Cell Lung Cancer |
Keywords: